[Correspondence] Adjuvant therapy in resectable gastric cancer—the CRITICS trial – Authors' reply

We appreciate the interest by Jingwen Wang and colleagues in our trial,1 about which they raise three important issues. First, we agree that the timing of randomisation does not allow for a direct comparison between postoperative chemotherapy and postoperative chemoradiotherapy because the subsets of patients who started postoperative treatment in each group could have different characteristics. However, we do not agree that the main purpose of the study was to compare only the postoperative treatment.

https://ift.tt/2KtbyuW